Literature DB >> 20528688

Persister cells.

Kim Lewis1.   

Abstract

Persisters are dormant variants of regular cells that form stochastically in microbial populations and are highly tolerant to antibiotics. High persister (hip) mutants of Pseudomonas aeruginosa are selected in patients with cystic fibrosis. Similarly, hip mutants of Candida albicans are selected in patients with an oral thrush biofilm. These observations suggest that persisters may be the main culprit responsible for the recalcitrance of chronic infectious disease to antimicrobial therapy. Screening knockout libraries has not produced mutants lacking persisters, indicating that dormancy mechanisms are redundant. Toxin/antitoxin (TA) modules are involved in persister formation in Escherichia coli. The SOS response leads to overexpression of the TisB toxin and persister formation. TisB is a membrane-acting peptide that apparently sends cells into dormancy by decreasing the proton motive force and ATP levels. Stress responses may act as general activators of persister formation. Proteins required for maintaining persisters may represent realistic targets for discovery of drugs capable of effectively treating chronic infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528688     DOI: 10.1146/annurev.micro.112408.134306

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  701 in total

1.  Ecological succession and viability of human-associated microbiota on restroom surfaces.

Authors:  Sean M Gibbons; Tara Schwartz; Jennifer Fouquier; Michelle Mitchell; Naseer Sangwan; Jack A Gilbert; Scott T Kelley
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata.

Authors:  Samantha C Halliwell; Matthew C A Smith; Philippa Muston; Sara L Holland; Simon V Avery
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 3.  Heterogeneous bacterial persisters and engineering approaches to eliminate them.

Authors:  Kyle R Allison; Mark P Brynildsen; James J Collins
Journal:  Curr Opin Microbiol       Date:  2011-09-19       Impact factor: 7.934

Review 4.  Messenger functions of the bacterial cell wall-derived muropeptides.

Authors:  Marc A Boudreau; Jed F Fisher; Shahriar Mobashery
Journal:  Biochemistry       Date:  2012-03-27       Impact factor: 3.162

Review 5.  Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.

Authors:  Marilyn N Martinez; Mark G Papich; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

6.  [Diagnosis and treatment of periprosthetic infections].

Authors:  M Lenz; G O Hofmann; T Mückley
Journal:  Unfallchirurg       Date:  2012-06       Impact factor: 1.000

7.  Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability.

Authors:  John-Jairo Aguilera-Correa; Antonio L Doadrio; Ana Conde; Maria-Angeles Arenas; Juan-Jose de-Damborenea; María Vallet-Regí; Jaime Esteban
Journal:  J Mater Sci Mater Med       Date:  2018-07-20       Impact factor: 3.896

8.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

9.  Candida albicans Amphotericin B-Tolerant Persister Formation is Closely Related to Surface Adhesion.

Authors:  Jing Sun; Zhigang Li; Haoyue Chu; Jing Guo; Guangshui Jiang; Qingguo Qi
Journal:  Mycopathologia       Date:  2015-09-18       Impact factor: 2.574

Review 10.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.